Back
Meta Platforms Vs. Akero Therapeutics Industry Stock Comparison
Buy
83
META
Meta Platforms
Last Price:
$720.00
Seasonality Move:
4.9%
Buy
69
AKRO
Akero Therapeutics
Last Price:
$49.93
Seasonality Move:
-13.61%
Buy
83
Meta Platforms (META)
is a Buy
Is Meta Platforms a Buy, Sell or Hold?
-
The current Meta Platforms [META] share price is $717.40. The Score for META is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
META is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.95. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms's stock price today?
-
The Meta Platforms share price today is $717.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.95The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
META Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 28.12 | Buy |
Relative Strength Index (14 RSI): | 80.22 | Buy |
Chaikin Money Flow: | 2960989 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.76 | Buy |
Relative Strength Index (14 RSI): | 64.15 | Buy |
Chaikin Money Flow: | -84584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.24 - 53.26) | Buy |
Bollinger Bands (100): | (23.77 - 40.49) | Buy |
META Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 703.33 | Buy |
20-day SMA: | 660.25 | Buy |
50-day SMA: | 627.59 | Buy |
200-day SMA: | 547.13 | Buy |
8-day EMA: | 700.94 | Buy |
20-day EMA: | 671.63 | Buy |
50-day EMA: | 635.53 | Buy |
200-day EMA: | 553.74 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.02 | Sell |
20-day SMA: | 42.05 | Buy |
50-day SMA: | 34.2 | Buy |
200-day SMA: | 27.85 | Buy |
8-day EMA: | 51.73 | Sell |
20-day EMA: | 45.31 | Buy |
50-day EMA: | 37.61 | Buy |
200-day EMA: | 30.47 | Buy |
Meta Platforms Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.31 per share, an increase this year of $2.56 per share, and an increase next year of $3.79 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Meta Platforms Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |